Actualités Forex

Swiss Market Ends Slightly Higher

Swiss Market Ends Slightly Higher

After a weak start, the Switzerland stock market recovered well, but stayed below the flat line almost right through the session on Monday, as investors stayed cautious and largely refrained from making significant moves.
RTTNews | il y a 1052
European Stocks Close Weak After Cautious Session

European Stocks Close Weak After Cautious Session

European stocks closed on a weak note on Monday as worries about corporate earnings outlook, energy crisis following Russia turning off Nord Stream 1, and fresh Covid-19 curbs in China weighed on sentiment.
RTTNews | il y a 1052
U.S. Dollar Higher With Inflation Data In Focus

U.S. Dollar Higher With Inflation Data In Focus

The U.S. dollar advanced against its major counterparts in the European session on Monday, as investors awaited U.S. inflation data due this week, after strong jobs data supported expectations for the aggressive policy tightening path by the Federal Reserve.
RTTNews | il y a 1052
Vail Resorts CFO Michael Barkin To Step Down

Vail Resorts CFO Michael Barkin To Step Down

Vail Resorts, Inc. (MTN) announced Monday that Executive Vice President and Chief Financial Officer Michael Barkin will be stepping down after nearly a decade in role to take time to pursue personal opportunities.
RTTNews | il y a 1052
more news
Lipocine Says FDA Oks LPCN 2101 IND For Adult Epilepsy Treatment

Lipocine Says FDA Oks LPCN 2101 IND For Adult Epilepsy Treatment

Biopharmaceutical company Lipocine Inc. (LPCN) announced Monday that the U.S. Food and Drug Administration (FDA) has accepted the company's Investigational New Drug Application (IND) for its neuroactive steroid (NAS) candidate, LPCN 2101, as a potential treatment for adults with epilepsy.
RTTNews | il y a 1052
Vertex Pharma To Acquire ViaCyte For $320 Mln In Cash

Vertex Pharma To Acquire ViaCyte For $320 Mln In Cash

Vertex Pharmaceuticals Inc. (VRTX) announced Monday that the company has entered into a definitive agreement under which Vertex will acquire privately-held biotechnology company ViaCyte for $320 million in cash.
RTTNews | il y a 1052
Bay Street Seen Opening On Negative Note

Bay Street Seen Opening On Negative Note

Lower futures and falling commodity prices point to a weak start for the Canadian stock market on Monday. Worries about a surge in coronavirus cases and fresh curbs in China are also likely to weigh.
RTTNews | il y a 1052
Australian Dollar Drops Amid Risk Aversion

Australian Dollar Drops Amid Risk Aversion

The Australian dollar fell against its most major counterparts in the European session on Monday, as a rise in COVID-19 cases in China and the energy crisis in Europe dampened risk sentiment.
RTTNews | il y a 1052

Stay up to date!

Add Actualités to your browser

Extension Picture